Optimizing the Continuum of Care for Patients with Pancreatic Cancer: A Case Study-Based Debate, Supported by Celgene International Sàrl
ALL SLIDES & ABSTRACTS not yet available
Selected Summarizing Slides:
![]() |
SLIDES |
Welcome and introduction
E Van Cutsem
Case 1: How does the use of adjuvant chemotherapy impact on nab-paclitaxel + gemcitabine use at relapse?
All, led by M Reni
Case 2: What is the optimal approach for patients with borderline resectable pancreatic cancer, and how does this impact on the subsequent treatment?
All, led by G Prager
Case 3: How does the management of locally advanced pancreatic cancer impact on treatment decisions for metastatic disease?
All, led by G Prager